Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Biosensors (Basel) ; 10(12)2020 Nov 24.
Artigo em Inglês | MEDLINE | ID: mdl-33255411

RESUMO

Integrating acoustic wave sensors into lab-on-a-chip (LoC) devices is a well-known challenge. We address this challenge by designing a microfluidic device housing a monolithic array of 24 high-fundamental frequency quartz crystal microbalance with dissipation (HFF-QCMD) sensors. The device features six 6-µL channels of four sensors each for low-volume parallel measurements, a sealing mechanism that provides appropriate pressure control while assuring liquid confinement and maintaining good stability, and provides a mechanical, electrical, and thermal interface with the characterization electronics. We validate the device by measuring the response of the HFF-QCMD sensors to the air-to-liquid transition, for which the robust Kanazawa-Gordon-Mason theory exists, and then by studying the adsorption of model bioanalytes (neutravidin and biotinylated albumin). With these experiments, we show how the effects of the protein-surface interactions propagate within adsorbed protein multilayers, offering essentially new insight into the design of affinity-based bioanalytical sensors.


Assuntos
Técnicas Biossensoriais/instrumentação , Microfluídica , Técnicas de Microbalança de Cristal de Quartzo
2.
Rev. esp. patol ; 52(4): 222-233, oct.-dic. 2019. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-191942

RESUMO

El mundo de la Patología cobra sentido de la mano de la Oncología Clínica, donde técnicas y tratamientos, biomarcadores y anticuerpos, comparten el objetivo de hallar nuevas posibilidades de intervención, más eficaces, menos agresivas y más integrales. En esta búsqueda, la evidencia muestra como la mecánica tisular afecta la carcinogénesis y como la heterogeneidad tumoral depende de la alteración metabólica del estroma y del efecto Warburg de las células malignas, regulado directamente por PD-1 y diana del tratamiento inmunoterápico. Proliferación y apoptosis dependen de la disfunción mitocondrial de la célula tumoral que determina el grado de quimio- y radiorresistencia. El estado de la microbiota intestinal determina la respuesta inmune, la estructura del microambiente del tumor y la respuesta al tratamiento oncológico, y el receptor de la vitamina D permite la reprogramación del estroma tumoral. En la actualidad, la colaboración entre los mundos de la investigación básica y clínica establece como zonas de desarrollo próximo el estudio del microambiente tumoral y la mecanoterapia molecular, el metabolismo y la inmunoterapia, la mitocondria y la oncogénesis, la microbiota y la quimioterapia, el eje psiconeuroendocrino y el desequilibrio homeostático, la epigenética y las posibilidades de reprogramación del fenotipo tumoral. De todos estos campos de conocimiento surgen nuevos biomarcadores, pronósticos y predictivos, que revisamos en este artículo al servicio de nuevas posibilidades de intervención terapéutica


Pathology and clinical oncology work hand in hand so that techniques and treatments, biomarkers and antibodies share the common goal of identifying integral new treatment regimens that are more effective and less aggressive. Evidence shows how tissue mechanics affect carcinogenesis and that tumor heterogeneity depends on metabolic stromal alteration and the Warburg effect of malignant cells, regulated directly by PD-1, becoming a target for immunotherapy. Proliferation and apoptosis depend on mitochondrial dysfunction in tumor cells, determining the grade of chemo/radio-resistance. The status of intestinal microbiota regulates immune response, tumor microenvironment structure and oncologic treatment response, whilst the Vitamin D receptor allows reprogramming of tumor stroma. Current collaboration between basic and clinical research paves the way for future investigation into areas such as tumor microenvironment and molecular mechanotherapy, metabolism and immunotherapy, mitochondria and oncogenesis, microbiota and chemotherapy, psychoneuroendocrine axis and homeostatic imbalance, epigenetics and reprogramming possibilities of the tumor phenotype. We review new prognostic and predictive biomarkers emerging from these fields of knowledge, opening up new therapeutic possibilities


Assuntos
Humanos , Neoplasias/patologia , Terapia de Alvo Molecular/métodos , Antineoplásicos Imunológicos , Resistencia a Medicamentos Antineoplásicos/imunologia , Biomarcadores Tumorais/análise , Microambiente Tumoral , Proteínas de Neoplasias/análise , Neuroimunomodulação/imunologia , Protocolos Antineoplásicos/classificação
3.
Rev Esp Patol ; 52(4): 222-233, 2019.
Artigo em Espanhol | MEDLINE | ID: mdl-31530405

RESUMO

Pathology and clinical oncology work hand in hand so that techniques and treatments, biomarkers and antibodies share the common goal of identifying integral new treatment regimens that are more effective and less aggressive. Evidence shows how tissue mechanics affect carcinogenesis and that tumor heterogeneity depends on metabolic stromal alteration and the Warburg effect of malignant cells, regulated directly by PD-1, becoming a target for immunotherapy. Proliferation and apoptosis depend on mitochondrial dysfunction in tumor cells, determining the grade of chemo/radio-resistance. The status of intestinal microbiota regulates immune response, tumor microenvironment structure and oncologic treatment response, whilst the Vitamin D receptor allows reprogramming of tumor stroma. Current collaboration between basic and clinical research paves the way for future investigation into areas such as tumor microenvironment and molecular mechanotherapy, metabolism and immunotherapy, mitochondria and oncogenesis, microbiota and chemotherapy, psychoneuroendocrine axis and homeostatic imbalance, epigenetics and reprogramming possibilities of the tumor phenotype. We review new prognostic and predictive biomarkers emerging from these fields of knowledge, opening up new therapeutic possibilities.


Assuntos
Biomarcadores Tumorais/análise , Neoplasias , Hipóxia Celular , Citocinas/metabolismo , Resistencia a Medicamentos Antineoplásicos , Epigênese Genética , Microbioma Gastrointestinal , Humanos , Imunoterapia , Inflamação , Linfócitos do Interstício Tumoral/imunologia , Mitocôndrias/metabolismo , Proteínas de Neoplasias/análise , Neoplasias/química , Neoplasias/imunologia , Neoplasias/patologia , Neoplasias/terapia , Neuroimunomodulação , Pesquisa , Células Estromais/patologia , Microambiente Tumoral
4.
Cancer Lett ; 461: 112-122, 2019 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-31325528

RESUMO

Cancer cells all share the feature of being immersed in a complex environment with altered cell-cell/cell-extracellular element communication, physicochemical information, and tissue functions. The so-called tumour microenvironment (TME) is becoming recognised as a key factor in the genesis, progression and treatment of cancer lesions. Beyond genetic mutations, the existence of a malignant microenvironment forms the basis for a new perspective in cancer biology where connections at the system level are fundamental. From this standpoint, different aspects of tumour lesions such as morphology, aggressiveness, prognosis and treatment response can be considered under an integrated vision, giving rise to a new field of study and clinical management. Nowadays, somatic mutation theory is complemented with study of TME components such as the extracellular matrix, immune compartment, stromal cells, metabolism and biophysical forces. In this review we examine recent studies in this area and complement them with our own research data to propose a classification of stromal changes. Exploring these avenues and gaining insight into malignant phenotype remodelling, could reveal better ways to characterize this disease and its potential treatment.


Assuntos
Matriz Extracelular/imunologia , Neoplasias/imunologia , Neoplasias/patologia , Células Estromais/imunologia , Microambiente Tumoral/imunologia , Animais , Humanos
5.
Rev. esp. patol ; 52(2): 92-102, abr.-jun. 2019. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-182695

RESUMO

El grupo de enfermedades al que nos referimos como «cáncer» comparte una estructura biológica conformada por un ecosistema complejo, donde se han alterado las relaciones intercelulares, los campos de información, el desarrollo y la función tisular. Más allá de las alteraciones genéticas de la célula tumoral, la demostración de un ecosistema alterado, con sus interconexiones a nivel sistémico, abre una nueva perspectiva de la biología y del comportamiento del cáncer. Diversas facetas del tumor, su morfología, clasificación, agresividad clínica, pronóstico y respuesta al tratamiento aparecen ahora bajo una visión integral que ofrece un nuevo horizonte de estudio, investigación y manejo clínico. La Teoría de la Mutación Somática en cáncer, vigente desde hace más de 100 años, se ve hoy completada por el estudio del microambiente tumoral, la matriz extracelular, las células estromales, la respuesta inmune, la inervación, la nutrición, la mitocondria, el metabolismo, el fluido intersticial, las propiedades mecánicas y electromagnéticas del tejido, y muchas otras áreas de conocimiento emergente, que abren la puerta a un ejercicio de reprogramación del fenotipo tumoral a través de la modificación de las claves ofrecidas por este nuevo paradigma. Su reconocimiento permite pasar de considerar el proceso oncológico como un problema celular a una alteración supracelular basada en la desorganización de los tejidos, inmersos en las relaciones del sistema complejo que conforma un ser vivo


The group of diseases that we call cancer share a biological structure formed by a complex ecosystem, with altered intercellular communication, information fields, development and tissue function. Beyond the genetic alterations of the tumor cell, the demonstration of an altered ecosystem, with interconnections at systemic levels, opens up a new perspective on cancer biology and behavior. Different tumor facets, such as morphology, classification, clinical aggressiveness, prognosis and response to treatment now appear under a comprehensive vision that offers a new horizon of study, research and clinical management. The Somatic Mutation Theory in cancer, in force for more than one hundred years, is now completed by the study of the tumor microenvironment, the extracellular matrix, the stromal cells, the immune response, the innervation, the nutrition, the mitochondria, the metabolism, the interstitial fluid, the mechanical and electromagnetic properties of the tissue and many other areas of emerging knowledge; thus opening the door to a reprogramming exercise of the tumor phenotype through the modification of the keys offered by this new paradigm. Its recognition makes it possible to go from considering the oncological process as a cellular problem to a supracellular alteration based on the disorganization of tissues, immersed in the relationships of the complex system of the living being


Assuntos
Humanos , Neoplasias/classificação , Gradação de Tumores/métodos , Microambiente Tumoral , Técnicas de Reprogramação Celular/tendências , Matriz Extracelular/patologia , Taxa de Mutação
6.
Rev Esp Patol ; 52(2): 92-102, 2019.
Artigo em Espanhol | MEDLINE | ID: mdl-30902384

RESUMO

The group of diseases that we call cancer share a biological structure formed by a complex ecosystem, with altered intercellular communication, information fields, development and tissue function. Beyond the genetic alterations of the tumor cell, the demonstration of an altered ecosystem, with interconnections at systemic levels, opens up a new perspective on cancer biology and behavior. Different tumor facets, such as morphology, classification, clinical aggressiveness, prognosis and response to treatment now appear under a comprehensive vision that offers a new horizon of study, research and clinical management. The Somatic Mutation Theory in cancer, in force for more than one hundred years, is now completed by the study of the tumor microenvironment, the extracellular matrix, the stromal cells, the immune response, the innervation, the nutrition, the mitochondria, the metabolism, the interstitial fluid, the mechanical and electromagnetic properties of the tissue and many other areas of emerging knowledge; thus opening the door to a reprogramming exercise of the tumor phenotype through the modification of the keys offered by this new paradigm. Its recognition makes it possible to go from considering the oncological process as a cellular problem to a supracellular alteration based on the disorganization of tissues, immersed in the relationships of the complex system of the living being.


Assuntos
Neoplasias/patologia , Microambiente Tumoral , Humanos , Neoplasias/genética
7.
Oncotarget ; 9(40): 26157-26170, 2018 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-29899849

RESUMO

Neuroblastoma is the most common extra-cranial solid pediatric cancer and causes approximately 15% of all childhood deaths from cancer. Although lymphatic vasculature is a prerequisite for the maintenance of tissue fluid balance and immunity in the body, little is known about the relationship between lymphatic vascularization and prognosis in neuroblastoma. We used our previously-published custom-designed tool to close open-outline vessels and measure the density, size and shape of all lymphatic vessels and microvascular segments in 332 primary neuroblastoma contained in tissue microarrays. The results were correlated with clinical and biological features of known prognostic value and with risk of progression to establish histological lymphatic vascular patterns associated with unfavorable histology. A high proportion of irregular intermediate lymphatic capillaries and irregular small collector vessels were present in tumors from patients with metastatic stage, undifferentiating neuroblasts and/or classified in the high risk. In addition, a higher lymphatic microvascularization density was found to be predictive of overall survival. Our findings show the crucial role of lymphatic vascularization in metastatic development and maintenance of tumor tissue homeostasis. These patterns may therefore help to indicate more accurate pre-treatment risk stratification and could provide candidate targets for novel therapies.

8.
Microb Cell ; 5(4): 184-197, 2018 Jan 26.
Artigo em Inglês | MEDLINE | ID: mdl-29610760

RESUMO

Several yeast species, belonging to Saccharomyces and non-Saccharomyces genera, play fundamental roles during spontaneous must grape fermentation, and recent studies have shown that mixed fermentations, co-inoculated with S. cerevisiae and non-Saccharomyces strains, can improve wine organoleptic properties. During active dry yeast (ADY) production, antioxidant systems play an essential role in yeast survival and vitality as both biomass propagation and dehydration cause cellular oxidative stress and negatively affect technological performance. Mechanisms for adaptation and resistance to desiccation have been described for S. cerevisiae, but no data are available on the physiology and oxidative stress response of non-Saccharomyces wine yeasts and their potential impact on ADY production. In this study we analyzed the oxidative stress response in several non-Saccharomyces yeast species by measuring the activity of reactive oxygen species (ROS) scavenging enzymes, e.g., catalase and glutathione reductase, accumulation of protective metabolites, e.g., trehalose and reduced glutathione (GSH), and lipid and protein oxidation levels. Our data suggest that non-canonical regulation of glutathione and trehalose biosynthesis could cause poor fermentative performance after ADY production, as it corroborates the corrective effect of antioxidant treatments, during biomass propagation, with both pure chemicals and food-grade argan oil.

9.
Histol Histopathol ; 33(5): 487-495, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29168879

RESUMO

Despite our deep understanding of neuroblastic tumors, some patients still suffer treatment failure, so pre-treatment risk stratification still requires improvement and the search for new therapeutic targets must continue. Here we correlated prognostic clinical and biological features of neuroblastic tumors with the density of extracellular matrix glycosaminoglycans (the main components of the extracellular matrix 'ground substance'), in nearly 400 primary samples. We also studied the relationship between the density of extracellular matrix glycosaminoglycans and the expression of B3GALT6, an enzyme required for their synthesis. We associated a decrease in glycosaminoglycans with neuroblastomas that were histopathologically poorly-differentiated or undifferentiated, as well as with metastatic disease, and 1p36 deleted tumors. This decrease in glycosaminoglycans was also related to abnormal nuclear B3GALT6 expression in neuroblastic cells. These findings point towards the importance of the ground substance in the aggressiveness of neuroblastic tumors, which should therefore be considered when developing novel therapies for treating neuroblastomas.


Assuntos
Neoplasias Encefálicas/genética , Deleção de Genes , Glicosaminoglicanos/metabolismo , Invasividade Neoplásica/genética , Neuroblastoma/genética , Neoplasias Encefálicas/patologia , Matriz Extracelular/genética , Matriz Extracelular/metabolismo , Galactosiltransferases/biossíntese , Galactosiltransferases/genética , Humanos , Processamento de Imagem Assistida por Computador , Imuno-Histoquímica , Estimativa de Kaplan-Meier , Análise em Microsséries , Invasividade Neoplásica/patologia , Metástase Neoplásica/genética , Neuroblastoma/patologia , Análise de Sobrevida
10.
Methods Mol Biol ; 1626: 189-198, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28608211

RESUMO

We provide an optimized protocol for a double staining technique to analyze superoxide dismutase enzymatic isoforms Cu-Zn SOD (Sod1) and Mn-SOD (Sod2) and catalase in the same polyacrylamide gel. The use of NaCN, which specifically inhibits yeast Sod1 isoform, allows the analysis of Sod2 isoform while the use of H2O2 allows the analysis of catalase. The identification of a different zymography profiling of SOD and catalase isoforms in different yeast species allowed us to propose this technique as a novel yeast identification and classification strategy.


Assuntos
Catalase/metabolismo , Ensaios Enzimáticos/métodos , Superóxido Dismutase/metabolismo , Leveduras/enzimologia , Eletroforese em Gel de Poliacrilamida/métodos , Peróxido de Hidrogênio/metabolismo , Isoformas de Proteínas/metabolismo , Saccharomyces cerevisiae/enzimologia , Saccharomyces cerevisiae/metabolismo , Cianeto de Sódio/metabolismo , Leveduras/metabolismo
11.
AMB Express ; 5(1): 75, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26621111

RESUMO

The tolerance of the yeast Saccharomyces cerevisiae to desiccation is important for the use of this microorganism in the wine industry, since active dry yeast (ADY) is routinely used as starter for must fermentations. Both biomass propagation and dehydration cause cellular oxidative stress, therefore negatively affecting yeast performance. Protective treatments against oxidative damage, such as natural antioxidants, may have important biotechnological implications. In this study we analysed the antioxidant capacity of pure chemical compounds (quercetin, ascorbic acid, caffeic acid, oleic acid, and glutathione) added to molasses during biomass propagation, and we determine several oxidative damage/response parameters (lipid peroxidation, protein carbonylation, protective metabolites and enzymatic activities) to assess their molecular effects. Supplementation with ascorbic, caffeic or oleic acids diminished the oxidative damage associated to ADY production. Based on these results, we tested supplementation of molasses with argan oil, a natural food-grade ingredient rich in these three antioxidants, and we showed that it improved both biomass yield and fermentative performance of ADY. Therefore, we propose the use of natural, food-grade antioxidant ingredients, such as argan oil, in industrial processes involving high cellular oxidative stress, such as the biotechnological production of the dry starter.

12.
Biotechnol J ; 9(8): 1055-64, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24644263

RESUMO

The production of active dried yeast (ADY) is a common practice in industry for the maintenance of yeast starters and as a means of long term storage. The process, however, causes multiple cell injuries, with oxidative damage being one of the most important stresses. Consequentially, dehydration tolerance is a highly appreciated property in yeast for ADY production. In this study we analyzed the cellular redox environment in three Saccharomyces cerevisiae wine strains, which show markedly different fermentative capacities after dehydration. To measure/quantify the effect of dehydration on the S. cerevisiae strains, we used: (i) fluorescent probes; (ii) antioxidant enzyme activities; (ii) intracellular damage; (iii) antioxidant metabolites; and (iv) gene expression, to select a minimal set of biochemical parameters capable of predicting desiccation tolerance in wine yeasts. Our results show that naturally enhanced antioxidant defenses prevent oxidative damage after wine yeast biomass dehydration and improve fermentative capacity. Based on these results we chose four easily assayable parameters/biomarkers for the selection of industrial yeast strains of interest for ADY production: trehalose and glutathione levels, and glutathione reductase and catalase enzymatic activities. Yeast strains selected in accordance with this process display high levels of trehalose, low levels of oxidized glutathione, a high induction of glutathione reductase activity, as well as a high basal level and sufficient induction of catalase activity, which are properties inherent in superior ADY strains.


Assuntos
Antioxidantes/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Vinho/microbiologia , Fermento Seco/análise , Biomarcadores/análise , Fermentação , Regulação Fúngica da Expressão Gênica , Glutationa/metabolismo , Saccharomyces cerevisiae/classificação , Saccharomyces cerevisiae/isolamento & purificação , Proteínas de Saccharomyces cerevisiae/genética , Trealose/metabolismo
13.
Appl Microbiol Biotechnol ; 97(10): 4563-76, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23354444

RESUMO

Aerobic organisms have devised several enzymatic and non-enzymatic antioxidant defenses to deal with reactive oxygen species (ROS) produced by cellular metabolism. To combat such stress, cells induce ROS scavenging enzymes such as catalase, peroxidase, superoxide dismutase (SOD) and glutathione reductase. In the present research, we have used a double staining technique of SOD and catalase enzymes in the same polyacrylamide gel to analyze the different antioxidant enzymatic activities and protein isoforms present in Saccharomyces and non-Saccharomyces yeast species. Moreover, we used a technique to differentially detect Sod1p and Sod2p on gel by immersion in NaCN, which specifically inhibits the Sod1p isoform. We observed unique SOD and catalase zymogram profiles for all the analyzed yeasts and we propose this technique as a new approach for Saccharomyces and non-Saccharomyces yeast strains differentiation. In addition, we observed functional correlations between SOD and catalase enzyme activities, accumulation of essential metabolites, such as glutathione and trehalose, and the fermentative performance of different yeasts strains with industrial relevance.


Assuntos
Catalase/metabolismo , Diferenciação Celular , Fermentação , Saccharomyces/enzimologia , Superóxido Dismutase/metabolismo , Biomassa , Saccharomyces/citologia , Saccharomyces/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...